Edaravone

Radicava

105 MG / 5 ML SuspensionCanadaMarketedAuthorised 9 Feb 2023

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Edaravone
Strength: 105 MG / 5 ML
Dosage form: Suspension
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 9 Feb 2023
Registration: DIN 02532611
Marketing authorisation holder: Shionogi INC.
ATC code: N07XX14
Group: Nervous system
Supply: PRESCRIPTION